Ophthalmic Co. Hits Ch. 11 With $64M Debt, Eyeing Sale

By Emily Lever · November 24, 2025, 11:24 AM EST

Clearside Biomedical, a company developing treatments for eye diseases, has filed for Chapter 11 protection in Delaware bankruptcy court with $64 million in debt, saying it will attempt to sell its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login